Oxidative inactivation of the proteasome in Alzheimer's disease

Free Radical Research

Volumn 41, Issue 6, 2007, Pages 673-680

  Cecarini, Valentina ^a,b   Ding, Qunxing ^a   Keller, Jeffrey N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

4 hydroxynonenal; Aging; Brain; Neurodegeneration; Neuroprostane; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; CARBONYL DERIVATIVE; CHYMOTRYPSIN; PROTEASOME; REDUCING AGENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OXIDATION; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 34249810042     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701286159     Document Type: Article

References (37)

1. Baumeister, W., Walz, J., Zühl, F. and Seemüller, E. (1998) The proteasome: Paradigm of a self-compartimentalizing protease. Cell, 92, pp. 367-380.
2. DeMartino, GN and Slaughter, CA (1999) The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem, 274, pp. 22123-22126.
3. Orlowski, M. and Wilk, S. (2000) Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys, 383, pp. 1-16.
4. Adams, J. (2003) The proteasome: Structure, function and role in the cell. Cancer Treat Rev, 29, pp. 3-9.
5. Davies, KJA (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie, 83, pp. 301-310.
6. Betarbet, B., Sherer, TB and Greenamyre, JT (2005) Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol, 191, pp. 17-27.
7. Keller, JN, Huang, FF, Zhu, H., Ho, YS and Kindy, MS (2000) Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab, 20, pp. 1467-1473.
8. Keller, JN, Hanni, KB and Markesbery, WR (2000) Impaired proteasome function in Alzheimer Disease. J Neurochem, 75, pp. 436-439.
9. Lam, YA, Pickart, CM, Alban, A., Landon, M., Jamieson, C., Ramage, R., Mayer, RJ and Layfield, R. (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci USA, 97, pp. 9902-9906.
10. Grune, T. (2000) Oxidative stress, aging and the proteasomal system. Biogerontology, 1, pp. 31-40.
11. Grune, T., Shringarpure, R., Sitte, N. and Davies, KJ (2001) Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol A Biol Sci Med Sci, 56, pp. 459-467.
12. Ding, Q., Markesbery, WR, Chen, Q. and Keller, JN (2005) Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci, 25, pp. 9171-9175.
13. Petersen, RC, Smith, GE, Waring, GC, Ivnik, RJ, Kokmen, E. and Tangelos, EG (1997) Aging, memory, and mild cognitive impairment. Int Psychogeriatr, 9, pp. 65-69.
14. Petersen, RC, Smith, GE, Waring, SC, Ivnik, RJ, Tangalos, RG and Kokmen, E. (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol, 56, pp. 303-308.
15. Friguet, B., Szweda, LI and Stadtman, ER (1994) Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys, 311, pp. 168-173.
16. Ding, Q., Lewis, JJ, Strum, KM, Dimayuga, E., Bruce-Keller, AJ, Dunn, JC and Keller, JN (2002) Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J Biol Chem, 277, pp. 13935-13942.
17. Barratt-Boyes, SM, Zimmer, MI, Harshyne, LA, Meyer, EM, Watkins, SC, Capuano, S., Murphey-Corb, M., Falo, LD and Donnenberg, AD (2000) Maturation and trafficking of monocyte-derived dendritic cells in monkeys: Implications for dendritic cell-based vaccines. J Immunol, 164, pp. 2487-2495.
18. Jones, LJ, Upson, RH, Haugland, RP, Panchuk-Voloshina, N. and Zhou, M. (1997) Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement. Anal Biochem, 251, p. 144.
19. Marcum, JL, Mathenia, JK, Chan, R. and Guttmann, RP (2005) Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease. Biochem Biophys Res Commun, 334, pp. 342-348.
20. Sayre, LM, Moreira, PI, Smith, MA and Perry, G. (2005) Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita, 41, pp. 143-164.
21. Smith, MA, Rottkamp, CA, Nunomura, A., Raina, AK and Perry, G. (2000) Oxidative stress in Alzheimer's disease. Biochim Biophys Acta, 1502, pp. 139-144.
22. Sohal, RS (2002) Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med, 33, pp. 37-44.
23. Cecarini, V., Gee, J., Fioretti, E., Amici, M., Angeletti, M., Eleuteri, AM and Keller, JN (2006) Protein oxidation and cellular homeostasis: Emphasis on metabolism. Biochim Biophys Acta
24. Roberts, LJ, Fessel, JP and Daves, SS (2005) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol, 15, pp. 143-148.
25. Roberts, LJ and Fessel, JP (2004) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids, 128, pp. 173-186.
26. Davies, SS, Amarnath, V., Montine, KS, Bernoud-Hubac, N., Boutaud, O., Montine, TJ and Roberts, LJ (2002) Effects of reactive γ-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. FASEB J, 16, pp. 715-717.
27. Ding, Q., Martin, S., Dimayuga, E., Bruce-Keller, AJ and Keller, JN (2006) LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid Redox Signal, 8, pp. 130-135.
28. Ding, Q., Reinacker, K., Dimayuga, E., Nukala, V., Drake, J., Butterfield, DA, Dunn, JC, Martin, S., Bruce-Keller, AJ and Keller, JN (2003) Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett, 546, pp. 228-232.
29. Ding, Q., Dimayuga, ED, Markesbery, WR and Keller, JN (2006) Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J, 20, pp. 1055-1063.
30. Ding, Q., Ceccarini, V. and Keller, JN (2007) Interplay between protein synthesis and degradation in the CNS: Physiological and pathological implications. Trends Neurosci, 30, pp. 31-36.
31. Farout, L., Mary, J., Vinh, J., Szweda, LI and Friguet, B. (2006) Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys, 453, pp. 135-142.
32. Ferrington, DA and Kapphahn, RJ (2004) Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett, 578, pp. 217-223.
33. Hyun, DH, Lee, MH, Halliwell, B. and Jenner, P. (2002) Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: A mechanism contributing to neurodegeneration?. J Neurochem, 83, pp. 360-370.
34. Farout, L. and Friguet, B. (2006) Proteasome function in aging and oxidative stress: Implications in protein maintenance failure. Antioxid Redox Signal, 8, pp. 205-216.
35. Friguet, B. (2006) Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett, 580, pp. 2910-2916.
36. Halliwell, B. (2006) Oxidative stress and neurodegeneration: Where are we now?. J Neurochem, 97, pp. 1634-1658.
37. Lee, MH, Hyun, DH, Jenner, P. and Halliwell, B. (2001) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J Neurochem, 78, pp. 32-41.